Skip to main content
Top
Published in: Aesthetic Plastic Surgery 3/2018

Open Access 01-06-2018 | Original Article

Myomodulation with Injectable Fillers: An Innovative Approach to Addressing Facial Muscle Movement

Author: Maurício de Maio

Published in: Aesthetic Plastic Surgery | Issue 3/2018

Login to get access

Abstract

Consideration of facial muscle dynamics is underappreciated among clinicians who provide injectable filler treatment. Injectable fillers are customarily used to fill static wrinkles, folds, and localized areas of volume loss, whereas neuromodulators are used to address excessive muscle movement. However, a more comprehensive understanding of the role of muscle function in facial appearance, taking into account biomechanical concepts such as the balance of activity among synergistic and antagonistic muscle groups, is critical to restoring facial appearance to that of a typical youthful individual with facial esthetic treatments. Failure to fully understand the effects of loss of support (due to aging or congenital structural deficiency) on muscle stability and interaction can result in inadequate or inappropriate treatment, producing an unnatural appearance. This article outlines these concepts to provide an innovative framework for an understanding of the role of muscle movement on facial appearance and presents cases that illustrate how modulation of muscle movement with injectable fillers can address structural deficiencies, rebalance abnormal muscle activity, and restore facial appearance.

Level of Evidence V

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Literature
1.
go back to reference Kahn DM, Shaw RB (2010) Overview of current thoughts on facial volume and aging. Facial Plast Surg 26(5):350–355CrossRefPubMed Kahn DM, Shaw RB (2010) Overview of current thoughts on facial volume and aging. Facial Plast Surg 26(5):350–355CrossRefPubMed
2.
go back to reference Erickson BP, Lee WW, Cohen J, Grunebaum LD (2015) The role of neurotoxins in the periorbital and midfacial areas. Facial Plast Surg Clin North Am 23(2):243–255CrossRefPubMed Erickson BP, Lee WW, Cohen J, Grunebaum LD (2015) The role of neurotoxins in the periorbital and midfacial areas. Facial Plast Surg Clin North Am 23(2):243–255CrossRefPubMed
3.
go back to reference Coleman KR, Carruthers J (2006) Combination therapy with BOTOX and fillers: the new rejuvenation paradigm. Dermatol Ther 19(3):177–188CrossRefPubMed Coleman KR, Carruthers J (2006) Combination therapy with BOTOX and fillers: the new rejuvenation paradigm. Dermatol Ther 19(3):177–188CrossRefPubMed
4.
go back to reference Carruthers J, Carruthers A, Tezel A, Kraemer J, Craik L (2010) Volumizing with a 20-mg/mL smooth, highly cohesive, viscous hyaluronic acid filler and its role in facial rejuvenation therapy. Dermatol Surg 36(Suppl 3):1886–1892CrossRefPubMed Carruthers J, Carruthers A, Tezel A, Kraemer J, Craik L (2010) Volumizing with a 20-mg/mL smooth, highly cohesive, viscous hyaluronic acid filler and its role in facial rejuvenation therapy. Dermatol Surg 36(Suppl 3):1886–1892CrossRefPubMed
5.
go back to reference Goldberg RA, Fiaschetti D (2006) Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg 22(5):335–341CrossRefPubMed Goldberg RA, Fiaschetti D (2006) Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg 22(5):335–341CrossRefPubMed
6.
go back to reference Callan P, Goodman GJ, Carlisle I, Liew S, Muzikants P, Scamp T, Halstead MB, Rogers JD (2013) Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study. Clin Cosmet Investig Dermatol 6:81–89CrossRefPubMedPubMedCentral Callan P, Goodman GJ, Carlisle I, Liew S, Muzikants P, Scamp T, Halstead MB, Rogers JD (2013) Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study. Clin Cosmet Investig Dermatol 6:81–89CrossRefPubMedPubMedCentral
7.
go back to reference Jones D, Murphy DK (2013) Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study. Dermatol Surg 39(11):1602–1611CrossRefPubMed Jones D, Murphy DK (2013) Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study. Dermatol Surg 39(11):1602–1611CrossRefPubMed
8.
go back to reference Carruthers JD, Glogau RG, Blitzer A (2008) Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies—consensus recommendations. Plast Reconstr Surg 121(Suppl 5):5S–30SCrossRefPubMed Carruthers JD, Glogau RG, Blitzer A (2008) Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies—consensus recommendations. Plast Reconstr Surg 121(Suppl 5):5S–30SCrossRefPubMed
9.
go back to reference Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaen P, Monheit GD, Rzany B, Viel M (2010) International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)—part I: upper facial wrinkles. J Eur Acad Dermatol Venereol 24(11):1278–1284CrossRefPubMed Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaen P, Monheit GD, Rzany B, Viel M (2010) International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)—part I: upper facial wrinkles. J Eur Acad Dermatol Venereol 24(11):1278–1284CrossRefPubMed
10.
go back to reference Raspaldo H, Baspeyras M, Bellity P, Dallara JM, Gassia V, Niforos FR, Belhaouari L (2011) Upper- and mid-face anti-aging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus—part 1. J Cosmet Dermatol 10(1):36–50CrossRefPubMed Raspaldo H, Baspeyras M, Bellity P, Dallara JM, Gassia V, Niforos FR, Belhaouari L (2011) Upper- and mid-face anti-aging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus—part 1. J Cosmet Dermatol 10(1):36–50CrossRefPubMed
11.
go back to reference Maas C, Kane MA, Bucay VW, Allen S, Applebaum DJ, Baumann L, Cox SE, Few JW, Joseph JH, Lorenc ZP, Moradi A, Nestor MS, Schlessinger J, Wortzman M, Lawrence I, Lin X, Nelson D (2012) Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review. Aesthet Surg J 32(1 Suppl):8S–29SCrossRefPubMed Maas C, Kane MA, Bucay VW, Allen S, Applebaum DJ, Baumann L, Cox SE, Few JW, Joseph JH, Lorenc ZP, Moradi A, Nestor MS, Schlessinger J, Wortzman M, Lawrence I, Lin X, Nelson D (2012) Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review. Aesthet Surg J 32(1 Suppl):8S–29SCrossRefPubMed
12.
go back to reference de Maio M (2003) Use of botulinum toxin in facial paralysis. J Cosmet Laser Ther 5(3–4):216–217CrossRefPubMed de Maio M (2003) Use of botulinum toxin in facial paralysis. J Cosmet Laser Ther 5(3–4):216–217CrossRefPubMed
13.
go back to reference de Maio M, Bento RF (2007) Botulinum toxin in facial palsy: an effective treatment for contralateral hyperkinesis. Plast Reconstr Surg 120(4):917–927CrossRefPubMed de Maio M, Bento RF (2007) Botulinum toxin in facial palsy: an effective treatment for contralateral hyperkinesis. Plast Reconstr Surg 120(4):917–927CrossRefPubMed
15.
go back to reference Lorenc ZP, Smith S, Nestor M, Nelson D, Moradi A (2013) Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy. Aesthetic Plast Surg 37(5):975–983CrossRefPubMed Lorenc ZP, Smith S, Nestor M, Nelson D, Moradi A (2013) Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy. Aesthetic Plast Surg 37(5):975–983CrossRefPubMed
16.
go back to reference Micheli-Pellegrini V (2011) About muscle insertions in man (Proposal for a new nomenclature of striated muscle). Acta Otorhinolaryngol Ital 31(3):167–176PubMedPubMedCentral Micheli-Pellegrini V (2011) About muscle insertions in man (Proposal for a new nomenclature of striated muscle). Acta Otorhinolaryngol Ital 31(3):167–176PubMedPubMedCentral
17.
go back to reference Goodmurphy CW, Ovalle WK (1999) Morphological study of two human facial muscles: orbicularis oculi and corrugator supercilii. Clin Anat 12(1):1–11CrossRefPubMed Goodmurphy CW, Ovalle WK (1999) Morphological study of two human facial muscles: orbicularis oculi and corrugator supercilii. Clin Anat 12(1):1–11CrossRefPubMed
18.
go back to reference Stal P, Eriksson PO, Eriksson A, Thornell LE (1987) Enzyme-histochemical differences in fibre-type between the human major and minor zygomatic and the first dorsal interosseus muscles. Arch Oral Biol 32(11):833–841CrossRefPubMed Stal P, Eriksson PO, Eriksson A, Thornell LE (1987) Enzyme-histochemical differences in fibre-type between the human major and minor zygomatic and the first dorsal interosseus muscles. Arch Oral Biol 32(11):833–841CrossRefPubMed
19.
go back to reference Ezure T, Hosoi J, Amano S, Tsuchiya T (2009) Sagging of the cheek is related to skin elasticity, fat mass and mimetic muscle function. Skin Res Technol 15(3):299–305CrossRefPubMed Ezure T, Hosoi J, Amano S, Tsuchiya T (2009) Sagging of the cheek is related to skin elasticity, fat mass and mimetic muscle function. Skin Res Technol 15(3):299–305CrossRefPubMed
20.
go back to reference Grelsamer RP, Klein JR (1998) The biomechanics of the patellofemoral joint. J Orthop Sports Phys Ther 28(5):286–298CrossRefPubMed Grelsamer RP, Klein JR (1998) The biomechanics of the patellofemoral joint. J Orthop Sports Phys Ther 28(5):286–298CrossRefPubMed
21.
go back to reference Doyle JR (2001) Palmar and digital flexor tendon pulleys. Clin Orthop Relat Res 383:84–96CrossRef Doyle JR (2001) Palmar and digital flexor tendon pulleys. Clin Orthop Relat Res 383:84–96CrossRef
22.
go back to reference Aiache AE, Ramirez OH (1995) The suborbicularis oculi fat pads: an anatomic and clinical study. Plast Reconstr Surg 95(1):37–42CrossRefPubMed Aiache AE, Ramirez OH (1995) The suborbicularis oculi fat pads: an anatomic and clinical study. Plast Reconstr Surg 95(1):37–42CrossRefPubMed
23.
go back to reference Rohrich RJ, Arbique GM, Wong C, Brown S, Pessa JE (2009) The anatomy of suborbicularis fat: implications for periorbital rejuvenation. Plast Reconstr Surg 124(3):946–951CrossRefPubMed Rohrich RJ, Arbique GM, Wong C, Brown S, Pessa JE (2009) The anatomy of suborbicularis fat: implications for periorbital rejuvenation. Plast Reconstr Surg 124(3):946–951CrossRefPubMed
24.
go back to reference Gray H (1974) The muscles and fasciae. In: Pick TP, Howden R (eds) Anatomy, descriptive and surgical. Running Press, Philadelphia, pp 306–315 Gray H (1974) The muscles and fasciae. In: Pick TP, Howden R (eds) Anatomy, descriptive and surgical. Running Press, Philadelphia, pp 306–315
25.
go back to reference de Maio M, Rzany B (2009) Botulinum toxin in aesthetic medicine. Springer, Berlin de Maio M, Rzany B (2009) Botulinum toxin in aesthetic medicine. Springer, Berlin
26.
go back to reference Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaen P, Monheit GD, Rzany B, Viel M (2010) International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)—part II: wrinkles on the middle and lower face, neck and chest. J Eur Acad Dermatol Venereol 24(11):1285–1295CrossRefPubMed Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaen P, Monheit GD, Rzany B, Viel M (2010) International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)—part II: wrinkles on the middle and lower face, neck and chest. J Eur Acad Dermatol Venereol 24(11):1285–1295CrossRefPubMed
27.
go back to reference Pessa JE, Zadoo VP, Garza PA, Adrian EK Jr, DeWitt AI, Garza JR (1998) Double or bifid zygomaticus major muscle: anatomy, incidence, and clinical correlation. Clin Anat 11(5):310–313CrossRefPubMed Pessa JE, Zadoo VP, Garza PA, Adrian EK Jr, DeWitt AI, Garza JR (1998) Double or bifid zygomaticus major muscle: anatomy, incidence, and clinical correlation. Clin Anat 11(5):310–313CrossRefPubMed
Metadata
Title
Myomodulation with Injectable Fillers: An Innovative Approach to Addressing Facial Muscle Movement
Author
Maurício de Maio
Publication date
01-06-2018
Publisher
Springer US
Published in
Aesthetic Plastic Surgery / Issue 3/2018
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-018-1116-z

Other articles of this Issue 3/2018

Aesthetic Plastic Surgery 3/2018 Go to the issue